VCYT insider trading
Open-market stock trades by Veracyte (VCYT) executives and directors: who bought or sold, how many shares, at what price and when.
VCYT insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 27, 2026 | Holstein Jens | director | Sell | 7,500 | $50.00 | $375.00K |
| Sep 24, 2026 | Holstein Jens | director | Sell | 7,500 | $47.00 | $352.50K |
| Oct 27, 2026 | EASTHAM KARIN | director | Sell | 14,850 | $50.00 | $742.57K |
| Oct 19, 2026 | Bhanji Muna | director | Sell | 1,864 | $43.70 | $81.46K |
| Sep 21, 2026 | Leite John | Global Chief Commercial Off | Sell | 4,015 | $40.00 | $160.60K |
| Sep 14, 2026 | Holstein Jens | director | Sell | 5,000 | $40.95 | $204.75K |
| Sep 4, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | 10,405 | $42.89 | $446.30K |
| Sep 4, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | 2,705 | $43.66 | $118.11K |
| Sep 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell | 2,477 | $42.81 | $106.03K |
| Sep 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell | 1,175 | $43.71 | $51.36K |
| Sep 4, 2026 | McGuire Annie | EVP, General Counsel | Sell | 2,154 | $42.79 | $92.17K |
| Sep 4, 2026 | McGuire Annie | EVP, General Counsel | Sell | 1,100 | $43.67 | $48.04K |
| Sep 1, 2026 | Bhanji Muna | director | Sell | 1,864 | $42.97 | $80.10K |
| Jun 18, 2026 | EASTHAM KARIN | director | Sell | 3,200 | $52.78 | $168.91K |
| Jun 18, 2026 | EASTHAM KARIN | director | Sell | 529 | $53.55 | $28.33K |
| Jun 4, 2026 | McGuire Annie | EVP, General Counsel | Sell | 1,400 | $49.31 | $69.03K |
| Jun 4, 2026 | McGuire Annie | EVP, General Counsel | Sell | 1,776 | $50.12 | $89.01K |
| Jun 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell | 1,600 | $49.28 | $78.85K |
| Jun 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell | 1,961 | $50.09 | $98.23K |
| Jun 4, 2026 | Stapley Marc | Chief Executive Officer | Sell | 138,051 | $50.12 | $6.92M |
| Jun 4, 2026 | Leite John | Global Chief Commercial Off | Sell | 13,975 | $50.07 | $699.73K |
| May 22, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | Sell | 24,000 | $45.40 | $1.09M |
| May 20, 2026 | EPSTEIN ROBERT S | director | Sell | 10,000 | $44.01 | $440.13K |
| May 6, 2026 | McGuire Annie | SVP, General Counsel | Sell | 5,102 | $38.05 | $194.13K |
| May 6, 2026 | McGuire Annie | SVP, General Counsel | Sell | 5,102 | $40.00 | $204.08K |
| Mar 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell | 4,400 | $35.55 | $156.41K |
| Mar 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell | 13,941 | $36.33 | $506.46K |
| Mar 4, 2026 | Stapley Marc | Chief Executive Officer | Sell | 19,244 | $35.56 | $684.23K |
| Mar 4, 2026 | Stapley Marc | Chief Executive Officer | Sell | 26,279 | $36.28 | $953.37K |
| Mar 4, 2026 | Leite John | Chief Commercial Officer-CLIA | Sell | 5,260 | $35.19 | $185.08K |
| Mar 4, 2026 | McGuire Annie | SVP, General Counsel | Sell | 4,994 | $35.29 | $176.26K |
| Mar 4, 2026 | McGuire Annie | SVP, General Counsel | Sell | 1,664 | $36.34 | $60.47K |
| Mar 2, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | 13,425 | $36.16 | $485.43K |
| Dec 16, 2025 | McGuire Annie | SVP, General Counsel | Sell | 10,639 | $43.13 | $458.84K |
| Dec 16, 2025 | McGuire Annie | SVP, General Counsel | Sell | 100 | $43.68 | $4.37K |
| Dec 5, 2025 | EASTHAM KARIN | director | Sell | 6,392 | $44.52 | $284.57K |
| Dec 5, 2025 | EASTHAM KARIN | director | Sell | 12,808 | $45.84 | $587.08K |
| Dec 5, 2025 | EASTHAM KARIN | director | Sell | 800 | $46.59 | $37.27K |
- VCYT insiders bought $0.00 and sold $17.52M in open-market trades over their last 38 filings.
Updated 2026-11-02 17:14 UTC